Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E24.08 EPS (ttm)5.91 Insider Own0.05% Shs Outstand2.69B Perf Week4.38%
Market Cap383.32B Forward P/E18.39 EPS next Y7.75 Insider Trans-12.77% Shs Float2.68B Perf Month8.08%
Income16.34B PEG3.80 EPS next Q1.80 Inst Own67.90% Short Float0.52% Perf Quarter7.06%
Sales72.53B P/S5.28 EPS this Y8.30% Inst Trans-0.02% Short Ratio2.59 Perf Half Y15.88%
Book/sh26.72 P/B5.33 EPS next Y7.84% ROA11.30% Target Price138.65 Perf Year23.97%
Cash/sh4.77 P/C29.82 EPS next 5Y6.34% ROE22.90% 52W Range109.32 - 142.98 Perf YTD23.60%
Dividend3.36 P/FCF43.40 EPS past 5Y11.20% ROI17.00% 52W High-0.41% Beta0.80
Dividend %2.36% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin69.40% 52W Low30.26% ATR1.78
Employees126400 Current Ratio1.30 Sales Q/Q1.90% Oper. Margin27.50% RSI (14)78.07 Volatility1.66% 1.10%
OptionableYes Debt/Eq0.48 EPS Q/Q-2.40% Profit Margin22.50% Rel Volume1.05 Prev Close142.04
ShortableYes LT Debt/Eq0.38 EarningsOct 17 BMO Payout53.80% Avg Volume5.37M Price142.40
Recom2.50 SMA206.18% SMA506.82% SMA20011.85% Volume5,634,311 Change0.25%
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
May-15-17Upgrade JP Morgan Neutral → Overweight
Jan-26-17Downgrade Wells Fargo Outperform → Market Perform
Jan-25-17Reiterated RBC Capital Mkts Outperform $133 → $128
Oct-19-16Reiterated UBS Buy $137 → $144
Jul-21-16Reiterated Deutsche Bank Hold $125 → $142
Jul-20-16Reiterated UBS Buy $126 → $137
Jul-20-16Reiterated RBC Capital Mkts Outperform $125 → $133
Oct-20-17 06:30PM  Healthcare ETF (VHT) Hits New 52-Week High Zacks
05:06PM  Four Tampa Bay billionaires make the Forbes 400 American City Business Journals
05:03PM  Johnson & Johnson Shuts Insulin Pump Business, Inks Other Deals
04:34PM  Dow, S&P 500 Hit Highs On IBM, Adobe, Tax Hopes; Netflix Reviews Mixed, GE, United Dive: Weekly Review Investor's Business Daily
03:35PM  Dow Industrials Lead, This Sector Heats Up; The Right Time To Sell GE? Investor's Business Daily
02:48PM  Celgene dives 10% after ditching key drug MarketWatch
12:00PM  Ask a Fool: The Dow Just Hit 23,000. What Does It Mean? Motley Fool
10:00AM  3 High-Yield Pharmaceutical Stocks Motley Fool
09:55AM  Dow 30 Stock Roundup: AmEx, IBM, JNJ, Goldman Beat Zacks
08:47AM  Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling Zacks
Oct-19-17 09:33PM  3 Heirloom Stocks to Hold Forever Motley Fool
07:07PM  Cramer explains how he lucked out in the crash of '87 CNBC Videos
07:02PM  Maneuvering the market sell-off CNBC Videos
07:01PM  Cramer: If Monday Was Black, Tuesday Was Even Darker
06:47PM  Cramer: How I lucked out in the crash of 1987 CNBC Videos
06:38PM  Cramer shares his playbook for maneuvering the market sel... CNBC Videos
04:11PM  Markets Right Now: S&P 500, Dow industrials eke out gains Associated Press
04:11PM  Markets Right Now: S&P 500, Dow industrials eke out gains Associated Press
03:20PM  Healthcare ETFs Head to Head: XLV vs. VHT Zacks
12:13PM  Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings Zacks
12:04PM  Alcobra Ltd (ADHD) Stock Fires Up To The Roof; Heres Why SmarterAnalyst
09:51AM  Can ImmunoGen's Key Pipeline Cancer Candidate Drive Growth? Zacks
09:16AM  Markets mark 30th anniversary of 'Black Monday' as Dow cr... CNBC Videos
08:47AM  NYSE floor trader says 1987-like crash could happen again, only this time, it would be faster CNBC
07:50AM  Earnings Review and Free Research Report: Johnson & Johnson EPS increased 13.0%; Revenue Advanced 10.3% ACCESSWIRE
07:26AM  Johnson & Johnson discards two hoped-for billion-dollar drugs MarketWatch
06:50AM  Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017 PR Newswire
Oct-18-17 09:00PM  3 Stocks to Buy and Hold for 100 Years Motley Fool
07:11PM  'Washington shenanigans' a great buying opportunity CNBC Videos
06:59PM  Cramer Remix: Johnson & Johnson is out of battleground territory CNBC
06:40PM  Cramer sees great buying opportunities in 'Washington's s... CNBC Videos
04:21PM  What to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
04:19PM  Dow ETFs Soar as the Index Hits 23,000 Zacks
10:44AM  Stock Market News For Oct 18, 2017 Zacks
10:25AM  Johnson & Johnson Stock Extends Breakout After Solid Q3 Investopedia
08:20AM  Today's Research Reports on Stocks to Watch: Johnson & Johnson and United Health Group ACCESSWIRE
07:42AM  Inside Johnson & Johnsons Performance in 3Q17 Market Realist
07:40AM  Are Markets In the Calm Before the Storm? InvestorPlace
07:21AM  Johnson & Johnson says recent hurricane activity had modest effect on company MarketWatch
06:31AM  What's Powering Johnson & Johnson's Impressive Quarterly Earnings? Motley Fool
02:15AM  Edited Transcript of JNJ earnings conference call or presentation 17-Oct-17 12:30pm GMT Thomson Reuters StreetEvents
12:03AM  [$$] Johnson & Johnson Outlook Buoyed by Drug Unit The Wall Street Journal
12:02AM  A big employer is finally addressing a major pain point for job applicants Quartz
Oct-17-17 09:12PM  3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report Motley Fool
07:05PM  Cramer Remix: The big problem that triggered Netflixs de... CNBC Videos
07:01PM  Cramer: Stocks May Be Cheaper Than We Think
06:59PM  Cramer Remix: The big problem that triggered Netflixs decline CNBC
06:56PM  Cramer offers 5 cheap stocks CNBC Videos
06:33PM  Cramer pushes back against 'peak earnings' theory with 5 ... CNBC Videos
06:22PM  Dow pierces 23,000 but ends below milestone Reuters
06:16PM  US STOCKS-Dow pierces 23,000 but ends below milestone Reuters
06:11PM  UnitedHealth and Morgan Stanley climb while Impax skids Associated Press
06:09PM  Business Highlights Associated Press
05:12PM  What Happened in the Stock Market Today Motley Fool
05:00PM  This hot trade is about to get even hotter: Trader CNBC Videos
05:00PM  Health care trades that still work: 6 picks CNBC Videos
04:55PM  Dow Component J&J Pops After Topping Views On Pharma Strength Investor's Business Daily
04:42PM  US STOCKS-Dow pierces 23,000 but finishes below milestone Reuters
04:38PM  Dow, S&P 500 end at records, boosted by health care stocks MarketWatch
04:15PM  Markets Right Now: US stocks close slightly higher Associated Press
04:05PM  Dow Jones Up, Apple In Buy Range, J&J Breaks Out; 2 Leading New IPOs To Watch Investor's Business Daily
03:56PM  US Pharma Mergers and Acquisitions in 3Q17 Market Realist
03:53PM  Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ) Motley Fool
03:51PM  J&J wins reversal of $72 million verdict over talc cancer risks Reuters
03:32PM  US STOCKS-Dow hits 23,000-mark, then backs off Reuters
03:01PM  New cancer drugs help J&J top profit estimates Reuters
03:00PM  New cancer drugs help Johnson & Johnson top profit estimates Reuters
02:42PM  New cancer drugs help J&J top profit estimates Reuters
02:33PM  Healthcare Drives Small Gains for Dow While Rest of Market Slips
02:12PM  The Latest: Appeals court tosses award in talcum powder case Associated Press
02:10PM  J&J wins reversal of $72 mln verdict over talc cancer risks Reuters
01:56PM  Healthcare Sector ETFs Pop on Earnings Support ETF Trends
01:48PM  Appeals court tosses $72 million award in talcum powder case Associated Press
01:33PM  Johnson & Johnson Looks Overvalued Today Morningstar
01:18PM  Johnson & Johnson Jumps on Pharma Strength Motley Fool
01:17PM  Nike among today's IQ100 leaders CNBC Videos
01:10PM  $72 million verdict against Johnson & Johnson in talc cas... CNBC Videos
01:00PM  Johnson & Johnson (JNJ) Beat Q3 Earnings, Ups Forecast InvestorPlace
12:55PM  Appeals court tosses $72 million verdict in lawsuit alleging Johnson & Johnson talcum powder contributed to cancer Associated Press
12:39PM  Why TransEnterix Stock Is Soaring Today Motley Fool
12:33PM  J&J: Puerto Rico Operations Still Open, Limited Impact From Hurricanes
12:23PM  [$$] Johnson & Johnson Outlook Buoyed by Drug Unit The Wall Street Journal
12:01PM  J&J Wins Reversal of First St. Louis Talc-Cancer Verdict Bloomberg
11:54AM  Markets Right Now: US stocks drift lower in midday trading Associated Press
11:50AM  UnitedHealth and J&J Drive Dow to 23,000 but Rest of Market Wavers
11:35AM  Johnson & Johnson tops Street 3Q forecasts, hikes forecast Associated Press
11:12AM  Dow Passes 23,000 for the First Time, Fueled by Strong Earnings Bloomberg
11:07AM  UnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains
10:40AM  Health-care ETF rallies, boosted by UnitedHealth and J&J results MarketWatch
10:37AM  Analysts Ratings and Recommendations for Johnson & Johnson Market Realist
10:37AM  J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales Zacks
10:13AM  J&J: Strong Earnings Is the Best Medicine
10:06AM  UnitedHealth, J&J stock rallies keeping Dow positive while Goldman drags MarketWatch
09:41AM  Stocks Rise As Dow Nears 23,000, UnitedHealth, J&J Lead Dow Investor's Business Daily
09:40AM  Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth 24/7 Wall St.
09:24AM  Stocks to Watch: Goldman Sachs, Morgan Stanley, Netflix, J&J, UnitedHealth, Snap, Facebook The Wall Street Journal
09:21AM  J&J's Puerto Rico plants running, can't rule out shortages Reuters
08:26AM  J&J CFO Caruso on 3Q Results, Diabetes Business Bloomberg Video
08:24AM  J&J (JNJ) Beats on Q3 Earnings & Sales, Ups 2017 View Zacks
08:14AM  Stock Futures Mixed as Wall Street Digests Morgan Stanley, Goldman Earnings
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising brand adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffJul 24Option Exercise72.54102,6927,449,278230,342Jul 26 11:49 AM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Sale133.14102,69213,672,629127,650Jul 26 11:49 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Option Exercise61.7582,5915,099,994226,693Jul 24 11:06 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Sale136.7282,59111,291,478144,102Jul 24 11:06 AM
Duato JoaquinExec VP, WW Chair, PharmaMar 03Option Exercise59.7650,0002,987,780118,536Mar 07 04:21 PM
Duato JoaquinExec VP, WW Chair, PharmaMar 03Sale123.6250,0006,181,14068,536Mar 07 04:21 PM
Kapusta Ronald AController, CAOFeb 28Option Exercise72.5414,5431,054,94944,507Mar 02 05:50 PM
Kapusta Ronald AController, CAOFeb 28Sale122.2614,5431,777,95429,964Mar 02 05:50 PM
Pruden Gary JExec VP, WW Chair, Med DevicesFeb 28Sale122.2116,2991,991,94343,630Mar 02 05:16 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale117.2922,0002,580,274127,650Feb 16 06:53 PM
Caruso Dominic JExec VP, Finance; CFOFeb 13Option Exercise0.0026,9470150,700Feb 15 10:00 PM
Kapusta Ronald AController, CAOFeb 13Option Exercise0.002,148030,052Feb 16 06:01 AM
Pruden Gary JExec VP, WW Chair, Med DevicesFeb 13Option Exercise0.0015,532063,405Feb 16 06:01 AM
Duato JoaquinExec VP, WW Chair, PharmaFeb 13Option Exercise0.0022,298075,814Feb 16 06:01 AM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0015,598068,899Feb 16 06:01 AM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.0084,2990280,617Feb 16 06:01 AM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 13Option Exercise0.0027,667069,436Feb 16 06:01 AM
Stoffels PaulusExec VP, Chief Scientific OffFeb 13Option Exercise0.0026,4470156,125Feb 16 06:01 AM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0014,6000114,866Feb 16 06:01 AM
Ullmann Michael HExec VP, General CounselFeb 01Option Exercise65.6227,7351,819,971119,190Feb 03 12:05 PM
Ullmann Michael HExec VP, General CounselFeb 01Sale112.8821,7352,453,44297,455Feb 03 12:05 PM
PRINCE CHARLESDirectorOct 21Buy114.1187599,84626,520Oct 25 01:52 PM